Systematic Literature Review for EU MDR
Listen now
Description
What’s involved in a systematic literature review for the EU MDR, and how should companies handle those steps?  In today’s episode, you’ll hear from Co-Founder and Operating Partner of CiteMed, Ethan Drower, on the topic of Systematic Literature Reviews for EU MDR Clinical Evaluation Reporting. In today’s conversation, we covered topics like where information for the literature review comes from, the types of tools used to make evaluations, and more. Listen to the episode to hear what Ethan has to say about the process of performing a CER, the mistakes and pitfalls he sees people make in the process, and what kinds of actionable steps companies can take. Some of the highlights of this episode include:What clinical evaluation reporting isThe big change in EUMDRThe process of performing a CERWhere people go to get the data for a CERHow to tell if a search is comprehensive enoughWhat mistakes Ethan has seen people makingThe process once the deliverable is submittedHow much time it takes for evaluations to go throughAdvice for companies going through the processMemorable quotes from Ethan Drower:“In comparison to the FDA, the big change, the big difference that’s happened with EUMDR is kind of a renewed scrutiny and focus on your actual data.” “It’s a compilation game, which is why nobody likes doing it. Because you have to bring in so many different pieces of data and different plans and that’s why it’s a difficult document to write.” “Once you’ve gone through the nightmare of pulling all this information together, now somebody has to read it.” “Don’t expect that what you searched and your process in the past, don’t expect it to just work and be glossed right over. It needs to be exceptionally thorough, and it needs to be iron tight.” Links:Ethan Drowers Linkedin Citemed Etienne Nichols LinkedIn Greenlight Guru Academy MedTech Excellence Community Greenlight Guru
More Episodes
Description: Join Devon Campbell in MedTech funding. He unveils startup red flags, from data integrity to product maturity. His message? Know your weaknesses, fill the gaps. Considering cold-calling other Founders? It works. Understand your their investment landscape first. Recognize that VCs and...
Published 08/31/23
Description: In this episode, Etienne Nichols and Ellie Reynolds explore FDA's Breakthrough Device designation. They discuss pursuing breakthrough status, aligning marketing strategies with FDA review, and navigating the medical device industry. This episode provides a roadmap for this complex...
Published 08/25/23